This study aimed to evaluate the impact of cholecalciferol treatment targeting a high normal concentration of 25(OH)D on biochemical markers of CKD-MBD, primarily 1,25(OH)2D and 1–84 PTH in hemodialysis patients. The gene discussed is PTH; the disease is chronic kidney disease.